Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide

Clin Neuropharmacol. 1995 Jun;18(3):277-9. doi: 10.1097/00002826-199506000-00009.

Abstract

We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use*
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use*
  • Female
  • Humans
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Pergolide / adverse effects*
  • Pergolide / therapeutic use*
  • Retroperitoneal Fibrosis / chemically induced*
  • Retroperitoneal Fibrosis / complications

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Pergolide